Package 62135-876-30

Brand: bupropion hydrochloride (xl)

Generic: bupropion hydrochloride (xl)
NDC Package

Package Facts

Identity

Package NDC 62135-876-30
Digits Only 6213587630
Product NDC 62135-876
Product ID 62135-876_155edd5e-1f89-6a6c-e063-6394a90aacdd
Description

30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-876-30)

Marketing

Marketing Status
Marketed Since 2024-03-28
Brand bupropion hydrochloride (xl)
Generic bupropion hydrochloride (xl)
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE (XL) ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "155edd5e-1f89-6a6c-e063-6394a90aacdd", "openfda": {"upc": ["0362135876302", "0362135875305"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8d9779e7-300e-4720-8ba5-2272b2506cd9"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 PACKAGE (62135-876-30)", "package_ndc": "62135-876-30", "marketing_start_date": "20240328"}], "brand_name": "BUPROPION HYDROCHLORIDE (XL)", "product_id": "62135-876_155edd5e-1f89-6a6c-e063-6394a90aacdd", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "62135-876", "generic_name": "BUPROPION HYDROCHLORIDE (XL)", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA208652", "marketing_category": "ANDA", "marketing_start_date": "20170821", "listing_expiration_date": "20261231"}